Trial intelligence / Profile preview

Tranexamic Acid in Burn Excisional Surgery

NCT05507983Phase 3Recruiting

Sponsor
Maasstad Ziekenhuis
Start
Dec 2021
Primary completion
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid, sponsored by Maasstad Ziekenhuis. Started Dec 2021; status: recruiting.

02

Drugs

tranexamic acid

Beyond the preview

Go deeper on NCT05507983.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05507983.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call